Dr. Aronhime is a consultant in the field of pharmaceutical polymorphism and pharmaceutical solid state science.
She has accumulated 27 years experience in her former position in Teva TAPI global R&D management as responsible for all the solid state aspects of the active pharmaceutical ingredients (APIs). In this key role she gained expertise in scientific analysis, characterization, development and research of polymorphism and all solid state attributes of API’s, along with the scientific support provided to patent litigations, prosecutions and clearances.
She was a key contributor to TEVA worldwide leadership position in the intellectual property domain by searching new crystal forms of APIs. Part of those became API ingredients in the marketed TEVA products.
Author and contributor to more than 100 patents and current applications.